# US 2013/0156742 A1 · Scaffold-Free Three Dimensional Nerve Fibroblast Constructs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156742 A1
- Document ID: US20130156742A1
- Status: Published application
- Kind: A1
- Application number: 13/805,486
- Filed: 2011-07-01
- Published: 2013-06-20
- Earliest claimed: 2010-07-01
- Assignees: The Regents of the University of Michigan
- Inventors: Lisa M. Larkin; Ellen M. Arruda; Jennifer Baltich; Aaron Adams; Leah Hatch-Vallier
- Web page: https://patentgrep.com/patent/US20130156742A1

## CPC

- A61K 35/33: Fibroblasts
- A61K 35/30: Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/383: {Nerve cells, e.g. dendritic cells, Schwann cells}
- A61L 27/3878: {Nerve tissue, brain, spinal cord, nerves, dura mater}
- A61L 27/3891: {as distinct cell layers}
- C12N 5/0622: {Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells}
- C12N 5/0697: {Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691)}
- A61L 2430/32: for nerve reconstruction
- C12N 2500/32: Amino acids
- C12N 2500/38: Vitamins
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/115: Basic fibroblast growth factor (bFGF, FGF-2)
- C12N 2501/15: Transforming growth factor beta (TGF-β)
- C12N 2502/08: cells of the nervous system
- C12N 2502/086: glial cells
- C12N 2502/1323: Adult fibroblasts
- C12N 2506/1307: from adult fibroblasts
- C12N 2506/1384: from adipose-derived stem cells [ADSC], from adipose stromal stem cells
- C12N 2533/10: Mineral substrates
- C12N 2533/52: Fibronectin; Laminin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention relates to scaffold-free three dimensional nerve fibroblast constructs and method of generating the nerve fibroblast constructs. The invention also relates to methods or repairing nerve transection and replacing damaged nerve tissue using the nerve fibroblast constructs of the invention.

## Claims

### Claim 1

A method of generating a scaffold-free, three-dimensional nerve fibroblast construct comprising the step of:
growing nerve cells on a static and confluent monolayer of fibroblasts without an exogenous scaffold and under conditions that induce the monolayer of fibroblasts to contract to generate a co-culture of fibroblast and nerve cells, the conditions further inducing the fibroblasts to contract and surround the nerve cells to generate a three-dimensional nerve fibroblast construct.

### Claim 2 (depends on 1)

The method of claim 1, wherein the fibroblasts and nerve cells are grown on a substrate.

### Claim 3 (depends on 1)

The method of claim 1, wherein the substrate is a culture plate coated with a silicon elastomer and laminin.

### Claim 4 (depends on 1)

The method of claim 1, wherein the monolayer of fibroblasts are grown in the absence of serum to induce a static state during the growth of the nerve cells on the confluent monolayer of fibroblasts.

### Claim 5 (depends on 1)

The method of claim 1, wherein the conditions that induce the monolayer of fibroblasts to contract comprise growing the nerve cells and fibroblasts in media comprising ascorbic acid and transforming growth factor-beta.

### Claim 6 (depends on 1)

The method of claim 1, wherein the fibroblasts are derived from adipose-derived stem cells.

### Claim 7 (depends on 1)

The method of claim 1, wherein the nerve cells are derived from adipose-derived stem cells.

### Claim 8 (depends on 1)

The method of claim 1, wherein the fibroblasts and the nerves cells are derived from adipose-derived stem cells.

### Claim 9 (depends on 1)

A scaffold-free, three-dimensional nerve fibroblast construct generated by any one of the methods of claim 1.

### Claim 10

A self-organizing, scaffold-free, three-dimensional nerve fibroblast construct comprising nerve cells surrounded by an external monolayer of fibroblasts.

### Claim 11 (depends on 10)

The self-organizing, scaffold-free, three-dimensional nerve fibroblast construct of claim 10 wherein the fibroblasts or nerve cells are derived from adipose-derived stem cells.

### Claim 12

(canceled)

### Claim 13 (depends on 10)

The self-organizing, scaffold-free, three-dimensional nerve fibroblast construct of claim 10 wherein the fibroblasts and the nerve cells are derived from adipose-derived stem cells.

### Claim 14

A three-dimensional co-culture comprising nerve cells and an external monolayer of fibroblasts, wherein the fibroblasts are contracted and surround the nerve cells.

### Claim 15 (depends on 14)

The three-dimensional co-culture of claim 14, wherein the fibroblasts or nerve cells are derived from adipose-derived stem cells.

### Claim 16

(canceled)

### Claim 17 (depends on 14)

The three-dimensional co-culture of claim 14, wherein the fibroblasts and the nerve cells are derived from adipose-derived stem cells.

### Claim 18 (depends on 1, 9, 10, 14)

A method of repairing a nerve transection in a subject comprising inserting the three-dimensional nerve fibroblast construct of any one of claim 9, 10 or 14 or a construct generated by a method of claim 1 in a subject in need to repair the nerve transection.

### Claim 19

(canceled)

### Claim 20 (depends on 1, 9, 10, 14)

A method of replacing damaged nerve tissue in a subject comprising inserting the three-dimensional nerve fibroblast construct of any one of claim 9, 10 or 14 or a construct generated by a method of claim 1 in a subject in need to replace the damaged nerve tissue.

### Claim 21

(canceled)

### Claim 22

A system for forming a three-dimensional nerve fibroblast construct comprising:
a confluent monolayer of fibroblasts provided on a substrate without an exogenous scaffold, the fibroblasts existing in a static state; and
nerve cells on the monolayer of fibroblasts, the nerve cells grown under conditions that induce the monolayer of fibroblasts to contract and surround the nerve cells.

### Claim 23 (depends on 22)

The system of claim 22, wherein the fibroblasts or nerve cells are derived from adipiose-derived stem cells.

### Claim 24

(canceled)

### Claim 25 (depends on 22)

The system of claim 22, wherein the fibroblasts and nerve cells are derived from adipose-derived stem cells.

### Claim 26

A self-organizing, scaffold-free, three-dimensional nerve fibroblast construct comprising nerve cells surrounded by an external monolayer of fibroblasts for use in repairing a nerve transaction or replacing damaged tissue.

### Claim 27

(canceled)

### Claim 28 (depends on 26)

The construct of claim 26, wherein the fibroblasts or nerve cells are derived from adipiose-derived stem cells.

### Claim 29

(canceled)

### Claim 30 (depends on 26)

The system of claim 26, wherein the fibroblasts and nerve cells are derived from adipose-derived stem cells.

### Claim at position 31

31-35. (canceled)
